pyrrolidine dithiocarbamate has been researched along with cyclic gmp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bara, A; Busse, R; Mülsch, A; Schini-Kerth, V | 1 |
| Dondlinger, LA; Pieper, GM | 1 |
2 other study(ies) available for pyrrolidine dithiocarbamate and cyclic gmp
| Article | Year |
|---|---|
Pyrrolidine dithiocarbamate selectively prevents the expression of the inducible nitric oxide synthase in the rat aorta.
Topics: Acetylcholine; Amino Acid Oxidoreductases; Analysis of Variance; Animals; Antioxidants; Aorta, Thoracic; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Induction; Interleukin-1; Male; Molsidomine; Muscle Relaxation; Muscle, Smooth, Vascular; NADPH Dehydrogenase; Nitric Oxide Synthase; Pyrrolidines; Radioimmunoassay; Rats; Rats, Wistar; Thiocarbamates; Vasodilator Agents | 1994 |
Antioxidant pyrrolidine dithiocarbamate prevents defective bradykinin-stimulated calcium accumulation and nitric oxide activity following exposure of endothelial cells to elevated glucose concentration.
Topics: Animals; Antioxidants; Aorta; Bradykinin; Calcium; Cattle; Cell Line; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Glucose; Kinetics; Nitric Oxide; Pyrrolidines; Signal Transduction; Thiocarbamates | 1998 |